EICHORCondition: Heart Failure · Sponsor: Analog Device, Inc.
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The primary purpose for this study is to support the hypothesis (pilot data) that the use of the Sensinel CPM system reduces the rate of HF-related events and the related healthcare cost. The study will also measure the impact on quality of care and patient satisfaction. In order to support the primary objective, the study will compare the outcomes and costs for patients using the Sensinel CPM system against those who are not. This can either be done using institutions' averages, if available, or through a control group.
This description comes directly from the study's public registry record.
Emily Wycallis · 978-435-1644 · emily.wycallis@analog.com
Always discuss trial participation with your own doctor first.
| Desert Oasis Healthcare | Palm Springs, California, United States | Completed |
| Baptist Health South Florida | Miami, Florida, United States | Recruiting |
| Orlando Health | Orlando, Florida, United States | Recruiting |
| Baystate Medical Center | Springfield, Massachusetts, United States | Active Not Recruiting |
| University of Nebraska Medical Center | Omaha, Nebraska, United States | Active Not Recruiting |
| Cone Health | Greensboro, North Carolina, United States | Completed |
| Prisma Health | Greenville, South Carolina, United States | Completed |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05650541